Skip to main content
Fig. 2 | Journal of Ovarian Research

Fig. 2

From: Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis

Fig. 2

High TET3 expression was correlated with poor clinicopathological features in serous ovarian cancer. TET3 mRNA expression were evaluated in 14 datasets from GEO comparing ovarian cancer in advanced stage (III-IV) serous adenocarcinoma vs early stage (I-II) serous adenocarcinoma vs normal tissue (a); in Grade I, Grade II, Grade III vs normal tissue (b). Nor, normal tissue

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us